Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1111/j.1398-9995.2007.01620.x | Allergic Rhinitis and its Impact on Asthma (ARIA) 2008* |
| https://doi.org/10.1097/hep.0000000000000520 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature |
| https://doi.org/10.1016/j.jhep.2023.06.003 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature |
| https://doi.org/10.1111/jdv.14891 | Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I |
| https://doi.org/10.1016/j.aohep.2023.101133 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature |
| https://doi.org/10.1111/jdv.14888 | Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II |
| https://doi.org/10.1186/1471-2466-6-13 | Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study |
| https://doi.org/10.1111/jvh.12248 | The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm |
| https://doi.org/10.1136/ard.2007.072157 | EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases |
| https://doi.org/10.1111/jdv.18345 | European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy |
| https://doi.org/10.1111/all.13208 | Allergen immunotherapy for allergic asthma: A systematic review and meta‐analysis |
| https://doi.org/10.1016/j.healthpol.2017.09.006 | Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) |
| https://doi.org/10.1186/s13073-016-0323-y | Making sense of big data in health research: Towards an EU action plan |
| https://doi.org/10.1111/all.13749 | |
| https://doi.org/10.1111/all.14425 | EAACI Biologicals Guidelines—Recommendations for severe asthma |
| https://doi.org/10.1186/gm259 | Systems medicine and integrated care to combat chronic noncommunicable diseases |
| https://doi.org/10.1111/jdv.18429 | European guideline ( |
| https://doi.org/10.1111/jvh.12247 | Historical epidemiology of hepatitis C virus ( |
| https://doi.org/10.1111/j.1365-2893.2011.01499.x | The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference* |
| https://doi.org/10.1111/all.15902 | |
| https://doi.org/10.1111/j.1398-9995.2007.01425.x | The prevalence, cost and basis of food allergy across Europe |
| https://doi.org/10.1186/2045-7022-2-21 | Research needs in allergy: an EAACI position paper, in collaboration with EFA |
| https://doi.org/10.1016/j.jaci.2016.12.940 | Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes |
| https://doi.org/10.1111/all.12686 | MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation |
| https://doi.org/10.1136/ard.2009.124958 | Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice |
| https://doi.org/10.1016/s2468-1253(20)30294-6 | Redefining fatty liver disease: an international patient perspective |
| https://doi.org/10.1111/jvh.12249 | Strategies to manage hepatitis |
| https://doi.org/10.1111/j.1398-9995.2010.02534.x | MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine |
| https://doi.org/10.1111/hex.12951 | Evaluating the “return on patient engagement initiatives” in medicines research and development: A literature review |
| https://doi.org/10.1016/j.jaci.2016.03.025 | MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis |
| https://doi.org/10.1016/j.buildenv.2015.08.011 | What does the scientific literature tell us about the ventilation–health relationship in public and residential buildings? |
| https://doi.org/10.1186/s13601-016-0137-4 | ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle |
| https://doi.org/10.1016/j.jaci.2018.08.049 | Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology |
| https://doi.org/10.1111/jdv.15634 | Atopic eczema: burden of disease and individual suffering – results from a large |
| https://doi.org/10.1097/aci.0b013e3282f3f42f | The voice of the patients: allergic rhinitis is not a trivial disease |
| https://doi.org/10.1183/16000617.00008114 | National and regional asthma programmes in Europe |
| https://doi.org/10.1186/s13601-018-0227-6 | MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence |
| https://doi.org/10.1186/s13601-019-0252-0 | Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma |
| https://doi.org/10.1111/all.14809 | Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines |
| https://doi.org/10.1111/all.12637 | Are allergic multimorbidities and IgE polysensitization associated with the persistence or re‐occurrence of foetal type 2 signalling? The |
| https://doi.org/10.1183/09031936.00053108 | The Brussels Declaration: the need for change in asthma management |
| https://doi.org/10.1159/000509057 | Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review |
| https://doi.org/10.1111/j.1398-9995.2010.02439.x | Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper |
| https://doi.org/10.2340/00015555-3102 | Out-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European Countries |
| https://doi.org/10.1111/all.12880 | Paving the way of systems biology and precision medicine in allergic diseases: the Me |
| https://doi.org/10.1007/s12072-018-9855-0 | Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype |
| https://doi.org/10.1093/ndt/gfac160 | The European Green Deal and nephrology: a call for action by the European Kidney Health Alliance |
| https://doi.org/10.1016/j.jaci.2012.01.047 | Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: A Mechanisms of the Development of Allergy (MeDALL) Seminar |
| https://doi.org/10.1186/s13601-017-0186-3 | European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017) |
| https://doi.org/10.4193/rhin17.253 | mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology |
| https://doi.org/10.1111/jvh.12120 | The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference |
| https://doi.org/10.1111/all.14408 | Real‐life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA |
| https://doi.org/10.1111/all.13701 | |
| https://doi.org/10.3389/fmed.2018.00231 | EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment |
| https://doi.org/10.1111/all.14422 | ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice |
| https://doi.org/10.1186/s12954-018-0230-1 | Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries |
| https://doi.org/10.2174/1381612820666140314115505 | Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies |
| https://doi.org/10.1007/s40290-022-00458-4 | Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions |
| https://doi.org/10.1186/s13601-016-0116-9 | Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) |
| https://doi.org/10.4193/rhin17.028 | EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis |
| https://doi.org/10.1111/all.12819 | European Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium (October 14, 2015) |
| https://doi.org/10.1111/all.15275 | Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air® real‐world data |
| https://doi.org/10.1007/s40271-021-00514-2 | The Perspectives of Patients with Chronic Diseases and Their Caregivers on Self-Management Interventions: A Scoping Review of Reviews |
| https://doi.org/10.1136/bmjgh-2023-013150 | Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy |
| https://doi.org/10.1111/hex.12997 | Including the patient voice in the development and implementation of patient‐reported outcomes in cancer clinical trials |
| https://doi.org/10.1183/13993003.00606-2022 | Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA) |
| https://doi.org/10.1016/s1470-2045(23)00157-2 | Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures |
| https://doi.org/10.1136/bmjopen-2019-034680 | Comparing the effectiveness and cost-effectiveness of self-management interventions in four high-priority chronic conditions in Europe (COMPAR-EU): a research protocol |
| https://doi.org/10.1111/hex.13191 | Evaluation of patient engagement in medicine development: A multi‐stakeholder framework with metrics |
| https://doi.org/10.1007/s43441-021-00282-z | Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action |
| https://doi.org/10.1016/j.jhepr.2022.100578 | What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association |
| https://doi.org/10.1186/s13601-017-0173-8 | CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report |
| https://doi.org/10.1016/s2352-3026(22)00226-5 | Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper |
| https://doi.org/10.1016/j.jhep.2023.12.031 | Inequities in primary liver cancer in Europe: The state of play |
| https://doi.org/10.1007/s12072-024-10732-z | APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 |
| https://doi.org/10.1158/2643-3230.bcd-21-0205 | Perspectives on the Risk-Stratified Treatment of Multiple Myeloma |
| https://doi.org/10.1371/journal.pone.0265153 | Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life |
| https://doi.org/10.1016/j.jhep.2020.08.009 | Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium |
| https://doi.org/10.1093/ecco-jcc/jjac135 | Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents |
| https://doi.org/10.1111/jdv.20639 | European Guideline ( |
| https://doi.org/10.1017/s0266462322000198 | Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force |
| https://doi.org/10.1183/23120541.00444-2022 | Definitions of non-response and response to biological therapy for severe asthma: a systematic review |
| https://doi.org/10.1136/bmj-2022-071913 | The European Health Data Space fails to bridge digital divides |
| https://doi.org/10.1016/j.jaip.2024.06.040 | Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024) |
| https://doi.org/10.1016/j.jhep.2023.01.008 | Post-liver transplantation patient experience |
| https://doi.org/10.12688/f1000research.22125.1 | The perspectives of patients and their caregivers on self-management interventions for chronic conditions: a protocol for a mixed-methods overview |
| https://doi.org/10.1111/pai.14129 | Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO |
| https://doi.org/10.2147/tcrm.s489873 | Adoption of Digital Therapeutics in Europe |
| https://doi.org/10.1016/s1470-2045(25)00150-0 | Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop |
| https://doi.org/10.1183/13993003.00691-2024 | Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma |
| https://doi.org/10.1093/sleep/zsae164 | Preventive medicine in obstructive sleep apnea—a systematic review and a call to action |
| https://doi.org/10.1017/s0266462321000167 | Development of an international template to support patient submissions in Health Technology Assessments |
| https://doi.org/10.36416/1806-3756/e20220270 | Environmental impact of inhaler devices on respiratory care: a narrative review |
| https://doi.org/10.1017/s0266462324004707 | Stakeholder perspectives on the current status and potential barriers of patient involvement in health technology assessment (HTA) across Europe |
| https://doi.org/10.1038/s41591-025-03759-8 | The People-First Liver Charter |
| https://doi.org/10.1002/clt2.70013 | Towards a common approach for managing food allergy and serious allergic reactions (anaphylaxis) at school. GA2LEN and EFA consensus statement |
| https://doi.org/10.1055/s-0044-1782527 | Role of Nasal Surgery in Adult Obstructive Sleep Apnea: A Systematic Review |
| https://doi.org/10.1016/s1470-2045(25)00520-0 | SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials |
| https://doi.org/10.1007/s12325-025-03191-x | Improving Care for People with Chronic Respiratory Diseases: Taking a Policy Lens |
| https://doi.org/10.1016/j.lanepe.2025.101408 | Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association |